Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Clinical trial data from the Phase 2 studies showed participants losing an average of 24.2% of their body weight over 48 weeks at the highest dose
Nature 555(7694):121125
For patients with Amyotrophic Lateral Sclerosis, glutathione has been shown to mitigate muscle weakness and improve overall quality of life
Those who have plateaued on Mounjaro or other GLP-1 class medications might benefit from Retatrutides additional glucagon receptor activation
10mg vial vs
The differences observed can be attributed to several factors inherent to real-world studies as compared to RCTs, and future work is needed to further characterize patient profiles most likely to benefit from GLP-1s with findings from both structured and unstructured clinical data modalities
US$ 25.86
US$ 25.55
US$ 25.25
